InVision Medical Technology

InVision Medical Technology

Private
Los Angeles, CaliforniaHealthcare & Life Scienceshttps://invisionmedtech.com

Last Round

Seed

Sep 28, 2022

Total Funding Raised

$500,000

Company Overview

InVision Medical Technology Corporation is an artificial intelligence (AI) company that develops software to improve the precision and accuracy of cardiovascular imaging. The company, which was part of Y Combinator's Summer 2022 batch, develops AI tools designed to streamline the interpretation of heart ultrasounds (echocardiograms) and help clinicians identify undiagnosed diseases. Its models are integrated into the clinical workflow to assist with diagnostic review and analysis. In May 2024, the company received U.S. FDA clearance for its Precision Left Ventricular Ejection Fraction (LVEF) software. In November 2023, InVision entered a collaboration with Alexion, AstraZeneca's rare disease unit, to develop an AI algorithm to accelerate the detection of cardiac amyloidosis.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Medical Devices, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

AI echocardiographycardiovascular diagnosticsAI medical imaginghealthcare AIcardiac amyloidosisSoftware as a Medical DeviceSaMDdiagnostic AIcardiology AImedical computer visionclinical workflow integrationFDA breakthrough devicePACS integrationEHR integration

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

InVision Medical Technology Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

InVision Medical Technology Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedSep 28, 2022

InVision Medical Technology Investors

Notable investors and investment history

InVision Medical Technology Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

InVision Medical Technology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about InVision Medical Technology's valuation, stock price, and market status.

Firmographic Details

HeadquartersLos Angeles, California
Year Founded2022
Last FundingSep 28, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.